Lasa Supergenerics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

50.10

50.10

50.10

40.67

40.67

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

33.61

46.58

68.18

107.96

118.24

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

83.71

96.68

118.29

148.63

158.92

Uses of funds

Fixed assets

Gross block

113.91

222.09

225.50

216.81

225.34

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

45.92

112.33

106.54

94.72

82.38

Net block

67.99

109.76

118.96

122.09

142.95

Capital work-in-progress

0.25

2.51

4.64

4.58

-

Investments

-

-

0.39

-

-

Net current assets

Current assets, loans & advances

33.30

38.60

39.86

72.54

64.91

Less : current liabilities & provisions

17.82

54.19

45.57

50.57

48.94

Total net current assets

15.48

-15.59

-5.70

21.97

15.97

Miscellaneous expenses not written

-

-

-

-

-

Total

83.71

96.68

118.29

148.63

158.92

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

501.01

501.01

501.01

406.73

406.73